Tenax Therapeutics, Inc.

10-Q Quarter ended 2026-06-30 Jul 31, 2026 8-K Results of operations (earnings release) Jul 31, 2026 8-K Other events Jul 2, 2026 8-K Entered a material agreement Jun 30, 2026 8-K Director or officer change; Other events Jun 29, 2026 8-K Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Director or officer change; Other events Apr 22, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release) Mar 10, 2026 8-K Director or officer change Jan 9, 2026 8-K Other events Dec 17, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Sep 16, 2025 8-K Entered a material agreement Sep 9, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Results of operations (earnings release) Mar 25, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 6, 2025 8-K Director or officer change Dec 4, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Director or officer change; Shareholder vote results Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Regulation FD disclosure Aug 12, 2024 8-K FORM 8-K Aug 6, 2024 8-K Director or officer change; Shareholder vote results Jun 13, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Other events Feb 23, 2024 8-K Entered a material agreement Feb 20, 2024